Shimoni Zvi, Bin Hanna, Bulvik Shlomo, Niven Mark, Hazzan Rawi, Mendelson Ella, Froom Paul
Department of Internal Medicine B, Laniado Hospital, Netanya;
National Center for Zoonotic Viruses, Central Virology Laboratory, Ministry of Health, Chaim Sheba Medical, Tel-Hashomer;
Clin Pract. 2012 Jan 27;2(1):e18. doi: 10.4081/cp.2012.e18. eCollection 2012 Jan 1.
The aim of the study was to determine whether intravenous gamma globulin (IVIG) treatment is effective in patients with West Nile Virus (WNV) neuroinvasive disease. We contacted hospital based infectious disease experts in Israeli hospitals to identify patients with WNV neuroinvasive disease who were treated with IVIG. The main outcome measure was neurological response after treatment. There were 12 patients who received IVIG and four improved within 48 h. Three patients died, 6 had partial recovery, and 3 recovered completely. Eleven of the 12 patients were infected with Israeli genotypes that are highly homologous to Europe/Africa viruses. The rapid response in some patients suggests that IVIG is effective, and might be used to treat patients with WNV neuroinvasive disease with IVIG.
该研究的目的是确定静脉注射丙种球蛋白(IVIG)治疗西尼罗河病毒(WNV)神经侵袭性疾病患者是否有效。我们联系了以色列医院中以医院为基础的传染病专家,以确定接受IVIG治疗的WNV神经侵袭性疾病患者。主要结局指标是治疗后的神经反应。有12名患者接受了IVIG治疗,其中4名在48小时内病情有所改善。3名患者死亡,6名部分康复,3名完全康复。12名患者中有11名感染了与欧洲/非洲病毒高度同源的以色列基因型。部分患者的快速反应表明IVIG是有效的,并且可用于治疗WNV神经侵袭性疾病患者。